Question

A 64-year-old man with chronic kidney disease presents with pallor, exertional breathlessness, and signs of heart failure. Investigations reveal normocytic anemia. What is the most appropriate next step in management?

• A. Oral iron
• B. Darbepoetin alfa
• C. Intravenous iron
• D. Blood transfusion

Hint:

In CKD anemia, evaluate and correct iron deficiency before starting or escalating erythropoiesis-stimulating agents.

Answer 1

The Correct Option is A

Step 1: Understanding the Question:
The question describes a patient with Chronic Kidney Disease (CKD) who has developed normocytic anemia, a common complication of declining renal function. The presence of heart failure signs and breathlessness indicates the clinical severity of the anemia. We need to determine the first-line treatment according to standard guidelines.
Step 2: Detailed Explanation:

Anemia of CKD: The primary cause of anemia in CKD is a deficiency in erythropoietin (EPO) production by the failing kidneys. However, absolute or functional iron deficiency is also extremely common due to impaired absorption and chronic inflammation.

Initial Assessment: Before initiating Erythropoiesis-Stimulating Agents (ESAs) like Darbepoetin alfa, it is mandatory to assess and optimize iron stores. ESAs are ineffective if the bone marrow lacks sufficient iron for hemoglobin synthesis.

Iron Supplementation: Guidelines (such as KDIGO) suggest that iron supplementation should be considered if an increase in hemoglobin is desired without starting an ESA, or if the patient is already on an ESA but has low iron indices (e.g., Transferrin saturation $\leq$ 30% and Ferritin $\leq$ 500 ng/mL).

Choice of Route: In non-dialysis CKD patients, a trial of oral iron (Option A) is often the first step before proceeding to intravenous iron (Option C). Oral iron is safer and less expensive, though it can cause gastrointestinal side effects.

Why not others? Blood transfusion (Option D) is reserved for acute, life-threatening symptomatic anemia or when other therapies fail. Darbepoetin (Option B) is only started after iron stores are replete.

Step 3: Final Answer:
The most appropriate next step in a CKD patient with symptomatic normocytic anemia is to ensure iron stores are optimized, starting with oral iron.